FDA
approval
· 2018-08-31
FDA Approved: ZENATANE — Supplemental Application (BluePoint Laboratories)
Summary
FDA approved a supplemental application for ZENATANE (isotretinoin) filed by BluePoint Laboratories, approving changes to the existing labeling.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for ZENATANE (ISOTRETINOIN)